Blood and tissue tests to monitor ovarian cancer using tumor DNA
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study uses a custom lab test on blood (and tumor tissue) to track ovarian cancer returning and to see how well treatment is working. It may help your care team monitor changes over time, especially after certain surgeries.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 18 or older
- You have advanced epithelial ovarian cancer and can have major surgery to remove as much tumor as possible
- Your ovarian cancer came back after platinum-based chemotherapy, and you are eligible for a second (repeat) surgery
- You agree to sign consent and let the researchers use your health data and samples
- You must be willing to provide both tumor tissue samples and blood samples for special genetic testing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing new blood tests that might help detect ovarian cancer earlier by looking for specific markers. It involves people with suspected ovarian cancer and healthy volunteers, and aims to improve how we diagnose the disease.
This trial tests a new blood test (OCS) that may help detect if ovarian cancer comes back after initial treatment. It is for people whose CA125 levels were normal at diagnosis.
This study looks at tumor tissue from ovarian cancer patients to find “biomarkers,” or lab signals, that may predict how the disease behaves or how it might respond to treatment. You may be asked for a biopsy of the relapsed (coming back) tumor or to use an existing archived tumor sample.
This study uses a simple blood test to look for tiny amounts of cancer DNA after you've finished your first treatment. It aims to see if this test can predict whether the cancer might come back, which could help guide future care.
This study looks for cancer DNA in your blood to understand advanced ovarian cancer better. It helps doctors see how the disease changes over time and may improve future treatments.
This study looks at blood samples from people with ovarian cancer to measure a marker called ctDNA (bits of tumor DNA in the blood). The goal is to see if changes in this marker before and after surgery can help predict or monitor the cancer.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.